Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Local demand high for Alphamab Oncology’s Hong Kong IPO

Hongjiang Li, Staff Writer
December 11, 2019 4:27 AM UTC
Updated on Dec 12, 2019 at 1:18 AM UTC

Local investors secured additional shares as Alphamab Oncology Ltd. (HKEX:9966) priced its IPO on the Hong Kong stock exchange Wednesday in a deal that raised HK$1.8 billion ($233.8 million) and valued the company at HK$9.1 billion as the exchange's biotech chapter approaches the end of its second year.

The company sold 179.4 million shares at HK$10.20, the top of its proposed range of HK$9.10-HK$10.20 (see “Alphamab Oncology Sets Sights on $220M IPO”)...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Alphamab Oncology Ltd.